Viewing Study NCT00256932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-06-04 @ 7:52 AM
Study NCT ID: NCT00256932
Status: COMPLETED
Last Update Posted: 2015-09-02
First Post: 2005-11-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bowel Dysfunction View
None Constipation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bowel dysfunction View
None constipation View
None gastrointestinal View
None opioids View
None pain View
None non-cancer pain View
None Opioid-induced View